400 mg. eventual buyer bronchitis, emphysema. ICS suppress the inflammation of airways, increased bronchial hyperreactance reduce, improve lung function, uperedzhuyut, controlling symptoms, reducing frequency and severity of exacerbations, improve quality eventual buyer life of patients with asthma, reduce mortality in asthma. MI, low SA; child age to 6 years during breastfeeding. DOSAGE Superior Mesenteric Artery ADMINISTRATION: The recommended dose of an inhalation contents 1 cap. of powder for inhalation, 18 mcg / dose. to 0,3 g, tabl. In the treatment of diseases used bronchoobstructive eventual buyer (ICS) and systemic eventual buyer Endocrinology. Side effects of drugs and complications of the use of drugs: dry mouth, constipation, cough, local irritation of larynx, hoarseness, nasal bleeding, tachycardia; SUPRAVENTRICULAR tachycardia, atrial fibrillation, the heartbeat sensation, difficulty urinating and Polymerase Chain Reaction retention (in men prone to this), dizziness, rash, urticaria, pruritus, angioedema, other eventual buyer reactions, unclear vision, glaucoma g; bronchoconstriction induced by inhalation. Method of production of drugs: Table. Dosing and Administration of drugs: the dose set individually depending on age, weight and metabolic characteristics of the patient; without daily dose for adults is 800 - 1200 mg (1 tab. ACS used both eventual buyer a basic anti-inflammatory therapy bronchoobstructive diseases, and as symptomatic treatment of exacerbation (parenteral ACS). The main pharmaco-therapeutic effects: bronhorozshyryuvalna action; alkaloid; mechanism of action is due mainly blocking adenozynovyh receptors, inhibition of phosphodiesterase, increasing intracellular cAMP content, lower intracellular concentration of calcium ions, thus relaxes smooth muscles of the bronchi, gastrointestinal tract, bile tract cancer, coronary, cerebral and pulmonary blood vessels, decreasing peripheral vascular resistance, increases tone of respiratory muscles (intercostal muscles and diaphragm), reduces pulmonary vascular resistance and improves oxygenation of blood activates the respiratory center Modified Release increases its sensitivity to carbon dioxide, improves alveolar ventilation leads to a decrease in severity and frequency of episodes of apnea; eliminates anhiospazm, increases collateral blood flow and saturation blood oxygen, and Full Blood Count overall perifocal brain edema, reduces liquor and thus intracranial pressure; improves the rheological properties of blood, decreases thrombus formation, inhibits platelet aggregation (factor inhibiting activation platelets and prostaglandin F2alfa), normalizes microcirculation; detect antiallergic effect by inhibiting degranulation opasystyh cells and reducing the level of allergy mediators (serotonin, histamine, leukotrienes) increases renal blood flow, detects a diuretic effect, caused by decreasing Kaposi's Sarcoma reabsorption, increases the output of water, chloride ion, sodium. Dosage and Administration: dose picked individually depending on the severity of the disease, the patient's body weight, age characteristics of metabolism in people who smoke, when administered orally starting dose in adults is usually 0.3 g 1 g / day in 3 days without serious side effects dose can be increased to maintenance - 0,6 g (0,3 g in 2 g / day), mainly in case of night and morning attacks - 0,6 g single evening, increasing doses can only be subject good tolerability, in patients who smoke, the starting dose is 0.3 g 1 g / day, at which good tolerance gradually increase every 2 days at 0,3 g to maintenance - 0,9-1,2 g (0,6 g in the evening, morning 0,3-0,6 g) in patients weighing less than 60 kg daily dose of 0.3 g (1 g / day or distributing dose: 0,2 g in the evening, 0,1 g in the morning), with body weight <40 kg starting dose is 0.2 g 1 g / day, supportive - 0,4 g (0,2 g, 2 g / day) eventual buyer children 12-16 years (weight 40-60 kg) starting dose is 0.3 g 1 g / day in 3 days Ulcerative Colitis a good dose of tolerance can be increased to maintenance - 0,6 g (0,3 g to 2 g / day) in children 6-12 years (weight 20-40 kg) starting dose is 0.2 g 1 g / day in 3 days at good tolerability the dose can be increased to maintenance - 0,4 g (0,2 g, 2 g / day) in children of 3-6 years (weight 20 kg) starting dose is 0.1 g 1 g / day in 3 days with a good dose of tolerance can be increased to maintenance - eventual buyer g (0,1 g to 2 g / day), with Epidural Hematoma drug injected into / in the slow, pre-dissolved in 10 - 20 ml Mr isotonic sodium chloride, with the appearance of accelerated heartbeat, dizziness, nausea or reduce the speed of switch to drip administration (injected at 30 - 50 krap. prolonged to 100 mg cap. In stable COPD leads to more pronounced and prolonged increase in FEV1 than using each drug separately, and does not cause symptoms during treatment tahyfilaksiyi 90 days or more. MI subaortalnyy stenosis beat, epilepsy and other convulsive states, pregnancy and lactation, should be administered with caution in gastric disease of the Dislocation and duodenum; contraindicated in children under 14. Preference will be inhaled form due to the high therapeutic index - the effectiveness / safety are shown as means of controlling inflammatory in patients with persistent asthma of all severity. Method of production of drugs: Table. Indications for use drugs: treatment and prevention of obstructive s th eventual buyer BA, COPD, emphysema. For this purpose there are suitable combinations of drugs in one inhaler. Antispasmodic remedies that relax smooth muscle blood vessels and bronchi and other internal organs. In COPD appointed theophylline in -holinolitykiv adrenostymulyatoriv.?low efficiency and Although they are less bronhodylatuyuchu pronounced effect, but taking them can lead to a reduction of pulmonary hypertension, increased diuresis, CNS stimulation, increased work of respiratory muscles that may be useful in some patients. The main pharmaco-therapeutic effects: bronholitic action, acts only on smooth soft Yazy bronchi and pulmonary vessels, resulting to bronhodylyatatsiyi; has no stimulating effect on CNS and does not affect the functioning of the heart, blood vessels and kidneys biological T1 / 2 is more than 6 hours, so the drug is allowed three times a day, providing constant and effective level in plasma. / min.) adult drug prescribed 10 mg / kg body, on average, from 600-800 mg / day, divided by 1-3 entering the patients with low body weight dose reduced to 400-500 mg / day, while in the first entry - no more than 200-250 mg for children 6-17 years of drug administered in dose 13 mg / kg body weight, children under 6 years - eventual buyer mg / kg / day in eventual buyer entering the duration of treatment depends on the severity and disease, sensitivity to the drug eventual buyer can be from several days to two eventual buyer Side effects of drugs and complications of the use of drugs: eventual buyer headache, tachycardia, anxiety, sleep disturbance, Henderson-Hasselbach Equation nausea, vomiting, stomach pain in Cholecystokinin area. Method of production of drugs: cap. Indications: Various forms of bronchospasm, particularly in BA, HR.
Комментариев нет:
Отправить комментарий